logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Antirheumatic Agent class drugs

    FiltersReset Filters
    8 results
    • cuprimine

      (penicillamine)
      Bausch Health US, LLC
      Usage: CUPRIMINE is indicated for treating Wilson's disease, cystinuria, and severe, active rheumatoid arthritis unresponsive to conventional therapy. It is not effective for ankylosing spondylitis. Treatment aims to reduce copper accumulation, manage cystine levels, and improve rheumatoid arthritis symptoms when other therapies fail.
    • depen

      (Penicillamine)
      Meda Pharmaceuticals Inc.
      Usage: DEPEN is indicated for treating Wilson’s disease, cystinuria, and severe rheumatoid arthritis in patients who have not responded to conventional therapy. It helps minimize copper intake and promotes copper excretion in Wilson’s disease, reduces cystine excretion to prevent stone formation in cystinuria, and assists in managing severe rheumatoid arthritis.
    • hydroxychloroquine

      (Hydroxychloroquine)
      Chartwell RX, LLC
      Usage: Hydroxychloroquine sulfate is indicated for the treatment of uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults and pediatric patients. It also offers malaria prophylaxis in areas without chloroquine resistance. Not recommended for complicated or resistant malaria cases.
    • hydroxychloroquine sulfate

      (Hydroxychloroquine Sulfate)
      Amneal Pharmaceuticals NY LLC
      Usage: Hydroxychloroquine sulfate tablets are indicated for treating uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus. Prophylaxis of malaria is also indicated in areas without chloroquine resistance. It is not recommended for complicated malaria or resistant strains.
    • hydroxychloroquine sulfate

      (HYDROXYCHLOROQUINE SULFATE)
      Dr. Reddy's Laboratories Inc.
      Usage: Hydroxychloroquine sulfate is indicated for treating uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults and pediatric patients. It is also used for malaria prophylaxis in areas without chloroquine resistance. Limitations apply to certain malaria strains and treatment scenarios.
    • leflunomide

      (Leflunomide)
      Lupin Pharmaceuticals, Inc.
      Usage: Leflunomide tablets USP are indicated for the treatment of adults with active rheumatoid arthritis (RA).
    • leflunomide

      (leflunomide)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (RA).
    • leflunomide

      (Leflunomide)
      Chartwell RX, LLC
      Usage: Leflunomide Tablets, USP are indicated for the treatment of adults with active rheumatoid arthritis (RA).